article thumbnail

Cardiology update: Should mRNA vaccine myocarditis be a contraindication to future COVID-19 vaccinations ?

Dr. Anish Koka

The case reports Case 1 involves a 26 year old man who developed pericarditis after the Pfizer vaccine. Pericarditis, an inflammation of the sac the heart lives in, developed about 7 days after the Pfizer vaccine. The diagnosis was made based on classic findings of inflammation on an electrocardiogram associated with acute chest pain.

article thumbnail

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

DAIC

Primary adverse events were defined as myocardial infarction, thromboembolism, transient ischemic attack, diaphragmatic paralysis, pneumothorax, heart block, pulmonary edema, vagal nerve injury, pericarditis, major vascular access complication or bleeding, death, stroke, or any other cerebrovascular accident. In: AF Symposium.; Int J Stroke.

article thumbnail

Vaccine myocarditis update from Korea

Dr. Anish Koka

While US public health authorities have been convinced from the very beginning about how safe and effective the new vaccines are, researchers in other countries with far smaller budgets have been testing that theory. But these rates are in line with a few other large datasets which lends credibility to the estimates.

article thumbnail

A COVID19 vaccine exemption letter

Dr. Anish Koka

4 An accompanying editorial 5 notes “Data from COVID-Heart provide reassuring evidence that myocarditis, once predicted to be an emerging public health crisis attributable to COVID-19, is relatively uncommon even among hospitalized patients and is less virulent than predicted during the early days of the pandemic.

article thumbnail

Auscultating Cardiac Surgery in the DR Congo

Global Cardiac Surgery

Finally, congenital heart diseases (CHD) are a major public health issue in this country. Together, they have operated nine Patent Ductus Arteriosus and two Chronic Constrictive Pericarditis between 2012 and 2015. The two aforementioned reasons also explain the high prevalence of rheumatic heart disease among Congolese children.